Most physicians favor state legislation that prohibits secondary sources, such as pharmacies, from selling prescribing information to data-mining companies for commercial purposes. However, 85% of doctors have no problem divulging their prescribing practices to the pharmaceutical industry through market research questionnaires. Those are some conclusions from a new Internet survey of physicians conducted by market research firm TNS Healthcare. TNS also found that to date, only a fraction of physicians (4%) have made use of AMA's opt-out program that keeps their prescribing information from being shared with pharmaceutical sales reps. The TNS study was conducted in January and covered 1,000 doctors.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
2 Commerce Drive
Cranbury, NJ 08512